Atmo Gas Capsule System for GI Transit Times
Gastroparesis, Slow Transit Constipation, GI Motility Disorders
Key Facts
About Atmo Biosciences
Atmo Biosciences is a commercial-stage diagnostics company focused on revolutionizing the assessment of gastrointestinal motility disorders. Its core technology is the Atmo Gas Capsule, an ingestible device that measures gases and other parameters directly within the GI tract to determine transit times. With FDA clearance secured in 2025 and a strong clinical publication record, the company is positioned to address a significant unmet need in the functional GI disorder market. Backed by a seasoned leadership team and a prestigious medical advisory board, Atmo is leveraging its proprietary sensing platform to improve diagnostic accuracy for common and debilitating gut conditions.
View full company profile